Mountain Crest Acquisition II (Mountain Crest Acquisition II) 5-Year Yield-on-Cost % : 0.00 (As of May. 11, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Mountain Crest Acquisition II 5-Year Yield-on-Cost %?

Mountain Crest Acquisition II's yield on cost for the quarter that ended in Oct. 2020 was 0.00.

The historical rank and industry rank for Mountain Crest Acquisition II's 5-Year Yield-on-Cost % or its related term are showing as below:

MCADU's 5-Year Yield-on-Cost % is not ranked ^*
in the Diversified Financial Services industry.
Industry Median: 3.655
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Mountain Crest Acquisition II's 5-Year Yield-on-Cost %

For the Shell Companies subindustry, Mountain Crest Acquisition II's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mountain Crest Acquisition II's 5-Year Yield-on-Cost % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Mountain Crest Acquisition II's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Mountain Crest Acquisition II's 5-Year Yield-on-Cost % falls into.

Mountain Crest Acquisition II 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Mountain Crest Acquisition II is calculated as

Yield-on-Cost

Dividend Yield %

Dividend Growth Rate)^5

Mountain Crest Acquisition II (NAS:MCADU) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.

Mountain Crest Acquisition II 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Mountain Crest Acquisition II's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.

Mountain Crest Acquisition II (Mountain Crest Acquisition II) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Mountain Crest Acquisition Corp II (NAS:MCADU) » Definitions » 5-Year Yield-on-Cost %

Comparable Companies

Traded in Other Exchanges

N/A

Address

311 West 43rd Street, 12th Floor, New York, NY, USA, 10036

Website

Mountain Crest Acquisition Corp II is a blank check company.

Executives

Frank Karbe	director, officer: See Remarks	C/O MYOVANT SCIENCES INC., 2000 SIERRA POINT PARKWAY, 9TH FLOOR, BRISBANE CA 94005
Elder Granger	director	5176 S. LEWISTON WAY, CENTENNIAL CO 80015
Richard H Carmona	director	1221 BROADWAY, OAKLAND CA 94612
Geoffrey M. Parker	director	15 RIORDAN PLACE, MENLO PARK CA 94025
Risa J Lavizzo-mourey	director	GE HEALTHCARE TECHNOLOGIES INC., 500 W. MONROE ST., CHICAGO IL 60661
Andrew J. Armanino	director	C/O CALIFORNIA BANCORP, 1300 CLAY STREET, FIFTH FLOOR, OAKLAND CA 94612
David P Perry	director, 10 percent owner, officer: See Remarks	1020 EAST MEADOW CIRCLE, PALO ALTO CA 94303
Suying Liu	director	311 WEST 43RD STREET, 12TH FLOOR, NEW YORK NY 10036
Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended	10 percent owner	548 MARKET STREET, #49404, SAN FRANCISCO CA 94104
David P. Perry 2015 Trust	10 percent owner	548 MARKET STREET, #49404, SAN FRANCISCO CA 94104
Mark A. Berman	officer: Chief Medical Officer	548 MARKET STREET, #49404, SAN FRANCISCO CA 94104
Kevin J Appelbaum	director, 10 percent owner, officer: Chief Executive Officer	4160 DUBLIN BLVD., SUITE 200, DUBLIN CA 94568
Mark Heinen	officer: See Remarks	548 MARKET STREET, #49404, SAN FRANCISCO CA 94104
Justin Zamirowski	officer: Chief Commercial Officer	548 MARKET STREET, #49404, SAN FRANCISCO CA 94104
Kristin Wynholds	officer: Chief Product Officer	548 MARKET STREET, #49404, SAN FRANCISCO CA 94104